Synexus Midlands Clinical Research Centre

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Amyloidosis3 trials
• Fatty liver disease (MASLD/MASH)1 trial
• Heart failure1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Eli Lilly and Company1 trial
• Intellia Therapeutics1 trial
• Ionis Pharmaceuticals, Inc.1 trial
• Novo Nordisk A/S1 trial

Running trials

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  NCT06128629· Phase 3· Intellia Therapeutics· Source

  Contact: Trial Manager at Intellia

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis2 recruiting
• Heart failure1 recruiting

Closed trials

• Completed

  CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study

  NCT06073574· Ionis Pharmaceuticals, Inc.· Source

• Completed

  A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

  NCT04166773· Phase 2· Eli Lilly and Company· Source